elisa based svnt kit genscript cpass sars-cov-2 neutralization antibody detection kit (GenScript corporation)
Structured Review

Elisa Based Svnt Kit Genscript Cpass Sars Cov 2 Neutralization Antibody Detection Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/genscript+cpass%2C+kit/cpass+sars+cov+2+neutralization+antibody+detection+kit/pmc09748424-69-13-17
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "A highly sensitive bead-based flow cytometric competitive binding assay to detect SARS-CoV-2 neutralizing antibody activity"
Article Title: A highly sensitive bead-based flow cytometric competitive binding assay to detect SARS-CoV-2 neutralizing antibody activity
Journal: Frontiers in Immunology
doi: 10.3389/fimmu.2022.1041860
Figure Legend Snippet: Comparison of ID50 values determined by the sVNT ELISA kit and iACE2/RBD-Fc model. ID50 values of 7 vaccine serum samples and 4 convalescent plasma samples were determined by the commercial ELISA based sVNT kit and the iACE2/RBD-Fc model. A panel of raw data for determination of neutralization activity of one vaccine serum by the sVNT ELISA kit and the iACE2/RBD-Fc model was shown in (A, B) , respectively. Two sample dilution response inhibition curves generated from the data shown in Panel (A, B) were plotted and shown in (C) . ID50 values of 11 samples determined by the two assays were compared and shown in (D) . The dash line was used to indicated the serum dilution fold with an activity to inhibit 50% binding of the RBD-Fc on the ACE2 bead. p value <0.05 is represented as *.
Techniques Used: Comparison, Enzyme-linked Immunosorbent Assay, Clinical Proteomics, Neutralization, Activity Assay, Inhibition, Generated, Binding Assay
Related Articles
other:Article Title: Trajectory of humoral responses to two doses of the ChAdOx1 nCoV-19 vaccination in patients receiving maintenance hemodialysis Article Snippet: A US-FDA-authorized sVNT assay (cPass SARS-CoV-2 Neutralization Antibody Detection Kit, Article Title: Targeting heptad repeats and fusion peptide: nanoparticle vaccine elicits mucosal immune response against SARS-CoV-2 variants. Article Snippet: The following antibodies were used: CD19-BV510 (Biolegend 115546), IgD-PE (Biolegend 405706), CD38-R718 (BD 752576), IgG1-PECY7 (Invitrogen M1-14D12), IgG2a-FITC (BD 562028), Streptavidin-BV421 (BD 563259), IgA-FITC (Invitrogen mA-6E1), CD4-R718 (BD 566939), CD8-BV510 (BD 563068), CD69-PE-CY7 (BD 552879), CD103-BV421 (Biolegend 121422), CD44-FITC (Biolegend 103006), CD95-PE-CY7 (BD 557653), GL7-FITC (Biolegend 144604), CXCR5-Biotin (Biolegend 145510), PD-1-APC (Invitrogen RMP1-30). Article Title: Evaluating the distribution and clustering of SARS-CoV-2 antibodies in dogs across the United States of America. Article Snippet: Serum samples collected from household dogs in this study were tested using blocking enzyme-linked immunosorbent assay (bELISA)31, Serum neutralization (SN)7, LumitTM Dx SARS-CoV-2 Immunoassay (Promega, Madison, Wisconsin), and Article Title: Evaluating the distribution and clustering of SARS-CoV-2 antibodies in dogs across the United States of America Article Snippet: Serum samples collected from household dogs in this study were tested using blocking enzyme-linked immunosorbent assay (bELISA) , Serum neutralization (SN) , LumitTM Dx SARS-CoV-2 Immunoassay (Promega, Madison, Wisconsin), and Article Title: Quantitative characterisation of extracellular vesicles designed to decoy or compete with SARS-CoV-2 reveals differential mode of action across variants of concern and highlights the diversity of Omicron. Article Snippet: As shown in Supplementary Table 1c, two different assays were applied for anti-SARS-CoV-2 screening according to manufacturer’s instructions: the Elecsys Anti-SARS-CoV-2 total anti-N antibody ECLIA (Roche Diagnostics) and a SARS-CoV-2 Surrogate Article Title: Comparative analysis of humoral immunity kinetics following three COVID-19 vaccines in a multi-ethnic cohort of medical students and healthcare professionals across Malaysia. Article Snippet: A02161 was utilized as the positive control when the SARS-CoV-2 Surrogate Inhibition:Article Title: Compositions including Sbi adjuvants and methods of use thereof Article Snippet: .. ACE2:RBD inhibition assay: The ability of vaccinated sera to inhibit ACE2:RBD binding was measured essentially as described in Nie, et al. (Nat Biotech 15: 3699-3715, 2020), using the SARS-CoV-2 Surrogate Binding Assay:Article Title: Compositions including Sbi adjuvants and methods of use thereof Article Snippet: .. ACE2:RBD inhibition assay: The ability of vaccinated sera to inhibit ACE2:RBD binding was measured essentially as described in Nie, et al. (Nat Biotech 15: 3699-3715, 2020), using the SARS-CoV-2 Surrogate Virus:Article Title: Compositions including Sbi adjuvants and methods of use thereof Article Snippet: .. ACE2:RBD inhibition assay: The ability of vaccinated sera to inhibit ACE2:RBD binding was measured essentially as described in Nie, et al. (Nat Biotech 15: 3699-3715, 2020), using the SARS-CoV-2 Surrogate Neutralization:Article Title: Compositions including Sbi adjuvants and methods of use thereof Article Snippet: .. ACE2:RBD inhibition assay: The ability of vaccinated sera to inhibit ACE2:RBD binding was measured essentially as described in Nie, et al. (Nat Biotech 15: 3699-3715, 2020), using the SARS-CoV-2 Surrogate Sequencing:Article Title: HTRF-based identification of small molecules targeting SARS-CoV-2 E protein interaction with ZO-1 PDZ2 Article Snippet: .. The Synthesized:Article Title: HTRF-based identification of small molecules targeting SARS-CoV-2 E protein interaction with ZO-1 PDZ2 Article Snippet: .. The Clone Assay:Article Title: HTRF-based identification of small molecules targeting SARS-CoV-2 E protein interaction with ZO-1 PDZ2 Article Snippet: .. The |